Medlive - A PlatformQ Health Brand
medliveofficial.bsky.social
Education for healthcare providers, patients & caregivers. 🩺💜👩🏻⚕️👨🏽⚕️ Make informed health decisions based on the latest science. Access Medlive here ➡️ https://bit.ly/3QAXfVt
👤 Joined on 27 February 2025
58
Followers
69
Following
284
Total Posts
📜 Kullanıcı Geçmişi
- 27 Şub 2025, 16:55
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@medliveofficial.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
AACI’s #PCLI will host a webinar with @medliveofficial.bsky.social on March 24 at 1 pm ET on improving clinical trial accruals with experts from @WinshipCancer and @BuffettCancer. Read more: bit.ly/4ssjyNY #AACIUpdate
Show PostAACI and @medliveofficial.bsky.social are advancing CAR T-cell therapy education through expert-guided video learning projects, supporting cancer center leaders & care teams with insights on emerging therapies. www.medlive.com/aaci
Show PostAACI has partnered with @medliveofficial.bsky.social to share on-demand education on CAR T-cell therapy in hematologic malignancies, including non-Hodgkin lymphoma and multiple myeloma. Expert-led insights cover referral & management considerations in the community setting. Watch now: bit.ly/45eV1lV
Show PostAACI and @medliveofficial.bsky.social present a CME program on bispecific CAR T-cell therapies for relapsed/refractory LBCL and DLBCL, with insights from 2025 hematology and lymphoma conferences. Watch on-demand and earn CME: bit.ly/4pY4hUR #OncologyEducation #CAR-T #Lymphoma #MedEd
Show PostAACI has partnered with @medliveofficial.bsky.social to share on-demand education on CAR T-cell therapy for non-Hodgkin lymphoma and multiple myeloma. Expert-led sessions cover referral pathways and management strategies for community practice. Watch now: bit.ly/45eV1lV
Show Post